Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart

Frazier, O.H.; Myers, Timothy J.; Jarvik, Robert; Westaby, Stephen; Pigott, David; Gregorič, Igor D.; Khan, Tehreen; Tamez, D.; Conger, Jeff L.; Macris, Michael P.

doi:10.1016/s0003-4975(00)02614-x

Cited by 117 publications

(71 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Survival of children after heart transplantation with pre-transplantation IPC (ECMO and Left Ventricular Bypass) and without mechanical support of blood circulation xas США) [57] и HeartWareHvad (HeartWare, Framingham, MA. США), осевые насосы HeartMate II (Thoratec Corporation США), Jarvik 2000 FlowMaker (Jarvik Heart, Inc., New York, CША) [58][59][60].…”

Section: результатыunclassified

Mechanical circulation support of the treatment for children with end-stage chronic heart failure

Готье¹,

Itkin²,

Дмитриева³

et al. 2017

RJTAO

View full text Add to dashboard Cite

1 ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России, Москва, Российская Федерация 2 Кафедра трансплантологии и искусственных органов ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет), Москва, Российская Федерация 3 Московский физико-технический институт (государственный университет), кафедра физики живых систем, Москва, Российская Федерация Механическая поддержка кровообращения за последние десятилетия стала одним из наиболее эффектив-ных средств лечения больных с терминальной сердечной недостаточностью. К сожалению, в педиатрии данный метод в основном используется для кратковременного подключения, и к нему относятся прежде всего экстракорпоральная мембранная оксигенация и левожелудочковый обход с помощью экстракорпо-рального подключения центробежных насосов. При этом применение данных методов у детей позволило значительно уменьшить смертность в листе ожидания на трансплантацию сердца. На сегодняшний день практически единственным методом длительной механической поддержки кровообращения у новорож-денных и детей младшего возраста является система паракорпорального подключения искусственных желудочков EXCOR, применение которых связано с большими проблемами тромбоосложнений. Имеется относительно небольшой клинический опыт использования полностью имплантируемых систем, разра-ботанных для взрослых, у детей старшего возраста. Поэтому, как показано в настоящем обзоре, задача создания систем длительной поддержки кровообращения для новорожденных и детей младшего возраста на основе имплантируемых насосов является актуальной. Over the last decades mechanical circulation support has become one of the most effective treatment methods for patients with terminal heart failure. Unfortunately, in pediatrics this method is generally used on a short-term basis and includes, first of all, extracorporeal membranous oxygenation and left ventricular bypass by means of the extracorporeal centrifugal pumps. Nevertheless, using of these methods in children allowed considerably reducing mortality on the waiting list for heart transplant. Today, practically the only method of long term

show abstract

Section: результатыunclassified

Mechanical circulation support of the treatment for children with end-stage chronic heart failure

Готье¹,

Itkin²,

Дмитриева³

et al. 2017

RJTAO

View full text Add to dashboard Cite

show abstract

“…Two case series studies evaluating the Jarvik 2000 LVAD were judged to be methodologically weak, [94][95][96][97][98][99][100] with poor reporting of the selection criteria for participants and the methods of data collection (Appendix 16). Outcome assessment was not blinded, providing the opportunity for ascertainment bias.…”

Section: Jarvikmentioning

confidence: 99%

“…80 Similarly, the study of the Novacor LVAD included male patients (100%) with a mean age of 47-51 years with ischaemic aetiology (40-80%), whereas the study of the Toyobo LVAD was of males (100%) with a mean age of 40 years and idiopathic dilated cardiomyopathy. One study of the Jarvik 2000 LVAD focused on males (66%) with a mean age of 47 years and suffering from ischaemic aetiology, 94 whereas in the other case study patient ages ranged from 30 to 70 years, 73% were male and 50% suffered from dilated cardiomyopathy and 50% from ischaemic cardiomyopathy. [94][95][96][97][98][99][100] The patients in the MicroMed DeBakey studies range in age from 33 to 65 years and were predominantly male.…”

Section: Generalisabilitymentioning

confidence: 99%

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Hutchinson¹,

Scott²,

Clegg³

et al. 2008

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAThe clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics...

show abstract

“…[28][29][30] The HeartMate II was FDA approved in January 2010 for use as destination therapy in adults with heart failure. Over 4000 HeartMate II devices have been implanted world-wide, 85 making it one of the most frequently used and successful VAD's in the current era.…”

Section: First-generation Vadsmentioning

confidence: 99%

Mechanical Circulatory Support

DiNardo

Zvara

2007

Anesthesia for Cardiac Surgery

View full text Add to dashboard Cite

Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart

Cited by 117 publications

References 22 publications

Mechanical circulation support of the treatment for children with end-stage chronic heart failure

Mechanical circulation support of the treatment for children with end-stage chronic heart failure

Cost–effectiveness of left ventricular-assist devices in end-stage heart failure

Mechanical Circulatory Support

Contact Info

Product

Resources

About